APPLICATION OF MAGNETIC-RESONANCE-IMAGING TO THE MEASUREMENT OF NEURODEGENERATION IN RAT-BRAIN - MRI DATA CORRELATE STRONGLY WITH HISTOLOGY AND ENZYMATIC ANALYSIS

被引:82
作者
ALLEGRINI, PR
SAUER, D
机构
[1] Biology Research Laboratories, Pharmaceuticals Division, Ciba-Geigy Ltd., CH-4002 Basel
关键词
NMDA RECEPTOR ANTAGONIST; MIDDLE CEREBRAL ARTERY OCCLUSION; QUINOLINIC ACID; NEURODEGENERATION; MAGNETIC RESONANCE IMAGING;
D O I
10.1016/0730-725X(92)90411-R
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Focal brain ischemia was induced by middle cerebral artery occlusion in the rat. The volume of cerebral damage was determined 2 days later by MRI in vivo and in the same animals histologically. The edema volume as measured by MRI and the histologically determined infarction was highly correlated. As a consequence, the neuroprotective effect of the N-methyl-D-aspartate (NMDA) receptor antagonists CGP 40116 and MK 801 were similar with both methods. Excitotoxic neurodegeneration in the rat striatum was induced by direct injection of quinolinic acid. The degree of damage was evaluated in vivo 1 day later by quantitative MRI, and 7 days later by measuring the activities of neuronal marker enzymes choline acetyltransferase and glutamic acid decarboxylase. Striatal damage assessed using the three approaches was highly correlated. Cerebroprotective efficacy of the NMDA receptor antagonist CGP 40116 was indistinguishable based on all methods. MRI was more reproducible than the enzymatic methods and was faster and simpler than histologic examination for routine analysis of excitotoxic damage and cerebroprotection in vivo in a pharmaceutical research environment.
引用
收藏
页码:773 / 778
页数:6
相关论文
共 21 条
[1]  
Zivin, Choi, Stroke therapy, Sci. Am., 265, pp. 56-63, (1991)
[2]  
McCulloch, Bullock, Teasdale, Excitatory amino acid antagonists: Opportunities for the treatment of ischaemic brain damage in man, Excitatory Amino Acids Antagonists, pp. 287-326, (1991)
[3]  
Choi, Excitotoxicity, Excitatory Amino Acids Antagonists, pp. 216-236, (1991)
[4]  
Meldrum, Protection against ischaemic neuronal damage by drugs acting on excitatory neurotransmission, Cerebrovasc. Brain Rev., 2, pp. 27-57, (1990)
[5]  
Park, Nehls, Graham, Teasdale, McCulloch, The glutamate antagonist MK-801 reduces focal ischaemic brain damage in the rat, Ann. Neurol., 24, pp. 543-551, (1988)
[6]  
Sauer, Massieu, Allegrini, Amacker, Schmutz, Fagg, Excitotoxicity, cerebral ischemia and neuroprotection by competitive NMDA receptor antagonists, Emerging Strategies in Neuroprotection, pp. 94-105, (1992)
[7]  
van Rijen, Verheul, van Echteld, Balazs, Lewis, Nasim, Tulleken, Effects of dextromethorphan on rat brain ischemia and reperfusion assessed by magnetic resonance spectroscopy, Stroke, 22, pp. 343-350, (1991)
[8]  
Steinberg, Saleh, Kunis, DeLaPaz, Zarnegar, Protective effect of N-methyl-d-aspartate antagonists after focal cerebral ischemia in rabbits, Stroke, 20, pp. 1247-1252, (1989)
[9]  
Tamura, Graham, McCulloch, Teasdale, Focal cerebral brain ischemia in the rat: I. Description of technique and early neuropathological consequences following middle cerebral artery occlusion, J. Cereb. Blood Flow Metab., 1, pp. 53-60, (1981)
[10]  
Schwarcz, Whetsell, Mangano, Quinolinic acid: Endogenous metabolite that can produce axon sparing lesions in rat brain, Science, 219, pp. 316-318, (1983)